Johnson & Johnson and its subsidiaries have approximately 131,900 employees worldwide engaged in the research and development, manufacture, and sale of a broad range of products in the healthcare field. The company is organized into two business segments: innovative medicine and medtech, and it competes with other companies both locally and globally. The competitive environment requires substantial investments in continuing research, reflecting a commitment to innovation and adaptation under challenging conditions. Management's objectives are guided by "our credo," emphasizing the importance of blending heart, science, and ingenuity to profoundly impact health for humanity. The company believes that health is everything and leverages its strength in healthcare innovation to build a world where complex diseases are prevented, treated, and cured. This operational flexibility enables the company to remain focused on addressing the unmet needs of society and invest for an enduring impact, ultimately delivering value to its stakeholders. The company invested $15.1 billion in research and development in 2023, demonstrating its commitment to creating life-enhancing innovations and value through partnerships. The diversity of its workforce empowers employees to lead with agility and urgency, allowing them to utilize the company's extensive resources to innovate and execute with excellence. The company has experienced sales growth across its segments, indicating resilience in navigating market challenges. In 2023, the innovative medicine segment achieved sales of $54.8 billion, reflecting a strategic focus on therapeutic areas such as immunology, oncology, and neuroscience. The medtech segment also saw significant growth, with sales of $30.4 billion, driven by advancements in surgical and interventional solutions. The company has initiated restructuring programs to streamline operations and exit certain markets, demonstrating adaptability in response to market dynamics. The ongoing commitment to research and development, alongside strategic acquisitions, positions the company to respond effectively to environmental disruptions and transform itself to emerge stronger from challenging situations. The company monitors global capital markets and has access to substantial sources of funds, ensuring sufficient resources to meet operational needs and manage financial risks. The ability to foresee, confront, and benefit from sudden disruptive changes is critical for the company's survival and growth. The company continues to adapt to economic and market factors, including inflation and geopolitical challenges, while maintaining a focus on responsible pricing and operational efficiency. The ongoing commitment to legal and regulatory compliance, alongside proactive measures in risk management, further enhances the company's resilience. The companyâ€™s strategic initiatives reflect a multifaceted approach to organizational resilience, ensuring that it can maintain positive adjustment under challenging conditions while pursuing its major objectives.